Gastroenterology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Wiley-Blackwell
Teriparatide outperforms alendronate in treating steroid-induced osteoporosis
November 9th, 2009
A recent study determined glucocorticoid-induced osteoporosis (OP) is now treatable with Teriparatide, a synthetic form of the human parathyroid hormone. Researchers found patients with glucocorticoid-induced OP who were treated with teriparatide for 36 months had a greater increase in bone mineral density (BMD) and fewer new vertebral fractures than those treated with alendronate. The findings of this study are published in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR). Glucocorticoids are steroid hormones that are naturally produced in the body or synthetically created compounds (drugs) used to reduce...
Source: Gastroenterology Week (2009-11-09)
|
